Selskabsmeddelelse13.11.2024, 15.15Bio Vitos Pharma AB (publ) appoints LAGO KAPITAL as liquidity provider
Selskabsmeddelelse12.02.2024, 13.50Bio Vitos Pharma AB: KFUM Kalmar and Bio Vitos Pharma enter into an agreement regarding a research study on Succifer
Selskabsmeddelelse20.12.2023, 07.30Bio Vitos Pharma AB: The European Patent Office EPO grants patent that is important to Bio Vitos Pharma
Selskabsmeddelelse04.05.2023, 14.00Hemcheck submits a formal application to Nasdaq for a decision on continued listing before the implementation of the Bio Vitos agreement
Selskabsmeddelelse26.04.2023, 16.20Hemcheck: Additional follow up order from the Foundation for Innovative New Diagnostics (FIND)
Selskabsmeddelelse05.04.2023, 22.50Hemcheck has received a first order from the university hospital Charité in Berlin
Selskabsmeddelelse16.03.2023, 13.10Hemcheck: Additional agreement with Bio Vitos Medical brings forward the time for calling the extraordinary general meeting by one week
Selskabsmeddelelse13.03.2023, 17.00Hemcheck has received a first follow up order from its Finnish distributor
Selskabsmeddelelse02.03.2023, 17.00Hemcheck has received an additional follow up order from its UK distributor
Selskabsmeddelelse28.02.2023, 21.15Hemcheck receives follow up order from research program in the United States
Selskabsmeddelelse03.02.2023, 16.30Hemcheck has received a follow up order from its French distributor
Selskabsmeddelelse24.01.2023, 17.00Hemcheck has received a first order from a leading hospital in Iceland
Selskabsmeddelelse23.01.2023, 11.00Hemcheck has received a follow up order from its Spanish distributor
Selskabsmeddelelse16.01.2023, 22.30Hemcheck has received another follow up order from its Irish distributor
Selskabsmeddelelse03.01.2023, 17.27Hemcheck extends agreement regarding previously communicated project with Region Skåne
Selskabsmeddelelse20.12.2022, 10.00Hemcheck has received a follow up order from its Irish distributor